Skip to content
SEARCH icon
  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeBiotech

      Biotech

      XORTX Announces Director Resignation
      Biotech

      XORTX Announces Director Resignation

      August 1, 2026
      Profusa Announces Signing of Option Agreement for the  Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
      Biotech

      Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs

      August 1, 2026
      IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
      Biotech

      IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      July 31, 2026
      Apnimed Announces Pricing of Upsized Initial Public Offering
      Biotech

      Apnimed Announces Pricing of Upsized Initial Public Offering

      July 31, 2026
      Agios Reports Second Quarter 2026 Financial Results and Provides Business Update
      Biotech

      Agios Reports Second Quarter 2026 Financial Results and Provides Business Update

      July 30, 2026
      Amneal Reports Second Quarter 2026 Financial Results
      Biotech

      Amneal Reports Second Quarter 2026 Financial Results

      July 30, 2026
      Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use
      Biotech

      Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use

      July 30, 2026
      INOVIO Announces Pricing of $20.0 Million Public Offering
      Biotech

      INOVIO Announces Pricing of $20.0 Million Public Offering

      July 30, 2026
      Fortrea Reports Second Quarter 2026 Results
      Biotech

      Fortrea Reports Second Quarter 2026 Results

      July 29, 2026
      Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026
      Biotech

      Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

      July 29, 2026
      « 1 … 3 4 5 6 7 … 82 »

       

      LATEST NEWS

      • Investing Best Dividend Stock if the Bank of Canada Cuts Rates
      • Investing News Can This Undervalued Stock Make You a Millionaire?
      • Investing News High Dividend Yield Stocks for Passive Income: Fiera Capital
      • Investing Top Canadian ETFs to Buy and Hold in Your TFSA

      Trading Whisperer

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Trading Whisperer.

      I want e-mail alerts, updates, and offers and agree to the Trading Whisperer privacy policy.

      Market Jar Media Inc. © 2026